カテゴリー： GlobalInfoResearch, 世界, 部品/材料

世界の組換えヒトタンパク質市場2022年：タンパク質生産物、タンパク質精製物

◆英語タイトル：Global Recombinant Human Proteins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY2327 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：97 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥501,120	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥751,680	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,002,240	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

組換えヒトタンパク質は、遺伝子工学の技術を用いて、ヒトの遺伝子から生成されるタンパク質を指します。これらのタンパク質は、特定の機能を持つために設計され、様々な医療や研究の分野で広く利用されています。ここでは、組換えヒトタンパク質の定義、特徴、種類、用途、関連技術について詳しく述べます。

組換えヒトタンパク質の定義としては、遺伝子組換え技術を用いて、特定のヒトタンパク質を生産するプロセスを通じて得られるタンパク質を指します。このプロセスでは、ヒトの遺伝子を特定の宿主細胞（通常は大腸菌、酵母、真核細胞など）に導入し、宿主細胞がその遺伝子を発現することで、目的のタンパク質を合成します。

組換えヒトタンパク質の特徴は、その生産方法にあります。従来の方法では、ヒトの組織から直接タンパク質を抽出する必要があり、得られる量が限られていたり、純度が低かったりすることがありました。しかし、組換え技術を用いることで、大量生産が可能になり、さらに目的のタンパク質を高純度で得ることができます。また、遺伝子の改変が可能であるため、機能を向上させたり、特定の修飾を加えたりすることもできます。

組換えヒトタンパク質の種類には、多くの医療用タンパク質や研究用タンパク質が含まれます。例としては、インスリン、成長ホルモン、抗体、サイトカイン、血液凝固因子などがあります。これらのタンパク質は、主に治療に使用されるものや、病理学的研究において重要な役割を果たします。

用途としては、まず医療分野での利用が挙げられます。特に、糖尿病の治療に用いられるインスリンや、成長ホルモン不足の治療に用いられるヒト成長ホルモンは、組換え技術によって生産されています。また、一部のがん治療に用いられるモノクローナル抗体も、組換え技術により生成され、特定の癌細胞に対する標的療法を可能にしています。

研究分野においても、組換えヒトタンパク質は重要な役割を担っています。これらのタンパク質は、細胞の機能やシグナル伝達を研究するためのツールとして用いられるほか、新しい薬剤や治療法の開発においても欠かせない存在です。たとえば、特定の病気に関連するタンパク質の機能を解析することにより、新たな治療ターゲットを見出すことができます。

関連技術としては、遺伝子克服技術や遺伝子編集技術（CRISPR/Cas9など）が挙げられます。これらの技術は、特定の遺伝子を改変し、目的のタンパク質を効率よく生成するために用いられます。また、大腸菌や酵母、哺乳類細胞などの宿主細胞の選択や培養条件の最適化も、組換えヒトタンパク質の生産効率を高める上で重要な要素です。

組換えヒトタンパク質の生産プロセスは、いくつかのステップから構成されています。まず、目的の遺伝子を特定し、それをクローニングして宿主細胞に導入します。次に、選択マーカーを用いて、成功した細胞を選別します。その後、細胞を培養してタンパク質を発現させ、最終的にタンパク質を精製します。この過程において、各ステップは厳密に管理され、最終産物の品質が確保されます。

最後に、組換えヒトタンパク質生産の倫理的側面も考慮する必要があります。特に、動物実験や遺伝子組換え技術の利用に関する法律や規制が存在し、それに従って研究や製造を行うことが求められます。また、患者に使用される医薬品としての安全性や有効性の検証も重要です。

以上のように、組換えヒトタンパク質は、医療や研究において非常に重要な役割を果たしており、その技術は今後も進展し続けると考えられています。新しい治療法の開発や基礎研究の進展に貢献することで、多くの人々の健康と福祉に寄与できることが期待されます。

組換えヒトタンパク質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の組換えヒトタンパク質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

組換えヒトタンパク質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・タンパク質生産物、タンパク質精製物

用途別セグメントは次のように区分されます。
・研究機関、医療

世界の組換えヒトタンパク質市場の主要な市場プレーヤーは以下のとおりです。
・Santa Cruz Biotechnology、OriGene、Cusabio、Amsbio、RayBiotech、Enzyme Research Laboratories、HYPHEN BIOMED

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、組換えヒトタンパク質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な組換えヒトタンパク質メーカーの企業概要、2019年～2022年までの組換えヒトタンパク質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な組換えヒトタンパク質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別組換えヒトタンパク質の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの組換えヒトタンパク質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での組換えヒトタンパク質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および組換えヒトタンパク質の産業チェーンを掲載しています。
・第13、14、15章では、組換えヒトタンパク質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Santa Cruz Biotechnology、OriGene、Cusabio、Amsbio、RayBiotech、Enzyme Research Laboratories、HYPHEN BIOMED
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：タンパク質生産物、タンパク質精製物
・用途別分析2017年-2028年：研究機関、医療
・組換えヒトタンパク質の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・組換えヒトタンパク質のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・組換えヒトタンパク質のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・組換えヒトタンパク質の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・組換えヒトタンパク質の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Recombinant Human Proteins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant Human Proteins market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Laboratories accounting for % of the Recombinant Human Proteins global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Protein Production segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Recombinant Human Proteins include Santa Cruz Biotechnology, OriGene, Cusabio, Amsbio, and RayBiotech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Recombinant Human Proteins market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Protein Production
Protein Purification
Market segment by Application can be divided into
Laboratories
Medical
The key market players for global Recombinant Human Proteins market are listed below:
Santa Cruz Biotechnology
OriGene
Cusabio
Amsbio
RayBiotech
Enzyme Research Laboratories
HYPHEN BIOMED
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Proteins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Human Proteins, with price, sales, revenue and global market share of Recombinant Human Proteins from 2019 to 2022.
Chapter 3, the Recombinant Human Proteins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Proteins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Human Proteins market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Human Proteins.
Chapter 13, 14, and 15, to describe Recombinant Human Proteins sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Recombinant Human Proteins Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Human Proteins Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Protein Production
1.2.3 Protein Purification
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Human Proteins Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Laboratories
1.3.3 Medical
1.4 Global Recombinant Human Proteins Market Size & Forecast
1.4.1 Global Recombinant Human Proteins Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Recombinant Human Proteins Sales in Volume (2017-2028)
1.4.3 Global Recombinant Human Proteins Price (2017-2028)
1.5 Global Recombinant Human Proteins Production Capacity Analysis
1.5.1 Global Recombinant Human Proteins Total Production Capacity (2017-2028)
1.5.2 Global Recombinant Human Proteins Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Human Proteins Market Drivers
1.6.2 Recombinant Human Proteins Market Restraints
1.6.3 Recombinant Human Proteins Trends Analysis
2 Manufacturers Profiles
2.1 Santa Cruz Biotechnology
2.1.1 Santa Cruz Biotechnology Details
2.1.2 Santa Cruz Biotechnology Major Business
2.1.3 Santa Cruz Biotechnology Recombinant Human Proteins Product and Services
2.1.4 Santa Cruz Biotechnology Recombinant Human Proteins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 OriGene
2.2.1 OriGene Details
2.2.2 OriGene Major Business
2.2.3 OriGene Recombinant Human Proteins Product and Services
2.2.4 OriGene Recombinant Human Proteins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Cusabio
2.3.1 Cusabio Details
2.3.2 Cusabio Major Business
2.3.3 Cusabio Recombinant Human Proteins Product and Services
2.3.4 Cusabio Recombinant Human Proteins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amsbio
2.4.1 Amsbio Details
2.4.2 Amsbio Major Business
2.4.3 Amsbio Recombinant Human Proteins Product and Services
2.4.4 Amsbio Recombinant Human Proteins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 RayBiotech
2.5.1 RayBiotech Details
2.5.2 RayBiotech Major Business
2.5.3 RayBiotech Recombinant Human Proteins Product and Services
2.5.4 RayBiotech Recombinant Human Proteins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Enzyme Research Laboratories
2.6.1 Enzyme Research Laboratories Details
2.6.2 Enzyme Research Laboratories Major Business
2.6.3 Enzyme Research Laboratories Recombinant Human Proteins Product and Services
2.6.4 Enzyme Research Laboratories Recombinant Human Proteins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 HYPHEN BIOMED
2.7.1 HYPHEN BIOMED Details
2.7.2 HYPHEN BIOMED Major Business
2.7.3 HYPHEN BIOMED Recombinant Human Proteins Product and Services
2.7.4 HYPHEN BIOMED Recombinant Human Proteins Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Recombinant Human Proteins Breakdown Data by Manufacturer
3.1 Global Recombinant Human Proteins Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Recombinant Human Proteins Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Recombinant Human Proteins
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Human Proteins Manufacturer Market Share in 2021
3.4.2 Top 6 Recombinant Human Proteins Manufacturer Market Share in 2021
3.5 Global Recombinant Human Proteins Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Recombinant Human Proteins Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Human Proteins Market Size by Region
4.1.1 Global Recombinant Human Proteins Sales in Volume by Region (2017-2028)
4.1.2 Global Recombinant Human Proteins Revenue by Region (2017-2028)
4.2 North America Recombinant Human Proteins Revenue (2017-2028)
4.3 Europe Recombinant Human Proteins Revenue (2017-2028)
4.4 Asia-Pacific Recombinant Human Proteins Revenue (2017-2028)
4.5 South America Recombinant Human Proteins Revenue (2017-2028)
4.6 Middle East and Africa Recombinant Human Proteins Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Recombinant Human Proteins Sales in Volume by Type (2017-2028)
5.2 Global Recombinant Human Proteins Revenue by Type (2017-2028)
5.3 Global Recombinant Human Proteins Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Recombinant Human Proteins Sales in Volume by Application (2017-2028)
6.2 Global Recombinant Human Proteins Revenue by Application (2017-2028)
6.3 Global Recombinant Human Proteins Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Human Proteins Sales by Type (2017-2028)
7.2 North America Recombinant Human Proteins Sales by Application (2017-2028)
7.3 North America Recombinant Human Proteins Market Size by Country
7.3.1 North America Recombinant Human Proteins Sales in Volume by Country (2017-2028)
7.3.2 North America Recombinant Human Proteins Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Human Proteins Sales by Type (2017-2028)
8.2 Europe Recombinant Human Proteins Sales by Application (2017-2028)
8.3 Europe Recombinant Human Proteins Market Size by Country
8.3.1 Europe Recombinant Human Proteins Sales in Volume by Country (2017-2028)
8.3.2 Europe Recombinant Human Proteins Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Recombinant Human Proteins Sales by Type (2017-2028)
9.2 Asia-Pacific Recombinant Human Proteins Sales by Application (2017-2028)
9.3 Asia-Pacific Recombinant Human Proteins Market Size by Region
9.3.1 Asia-Pacific Recombinant Human Proteins Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Recombinant Human Proteins Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Recombinant Human Proteins Sales by Type (2017-2028)
10.2 South America Recombinant Human Proteins Sales by Application (2017-2028)
10.3 South America Recombinant Human Proteins Market Size by Country
10.3.1 South America Recombinant Human Proteins Sales in Volume by Country (2017-2028)
10.3.2 South America Recombinant Human Proteins Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Human Proteins Sales by Type (2017-2028)
11.2 Middle East & Africa Recombinant Human Proteins Sales by Application (2017-2028)
11.3 Middle East & Africa Recombinant Human Proteins Market Size by Country
11.3.1 Middle East & Africa Recombinant Human Proteins Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Recombinant Human Proteins Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Recombinant Human Proteins and Key Manufacturers
12.2 Manufacturing Costs Percentage of Recombinant Human Proteins
12.3 Recombinant Human Proteins Production Process
12.4 Recombinant Human Proteins Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Recombinant Human Proteins Typical Distributors
13.3 Recombinant Human Proteins Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Recombinant Human Proteins Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Recombinant Human Proteins Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 4. Santa Cruz Biotechnology Major Business
Table 5. Santa Cruz Biotechnology Recombinant Human Proteins Product and Services
Table 6. Santa Cruz Biotechnology Recombinant Human Proteins Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. OriGene Basic Information, Manufacturing Base and Competitors
Table 8. OriGene Major Business
Table 9. OriGene Recombinant Human Proteins Product and Services
Table 10. OriGene Recombinant Human Proteins Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Cusabio Basic Information, Manufacturing Base and Competitors
Table 12. Cusabio Major Business
Table 13. Cusabio Recombinant Human Proteins Product and Services
Table 14. Cusabio Recombinant Human Proteins Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Amsbio Basic Information, Manufacturing Base and Competitors
Table 16. Amsbio Major Business
Table 17. Amsbio Recombinant Human Proteins Product and Services
Table 18. Amsbio Recombinant Human Proteins Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 20. RayBiotech Major Business
Table 21. RayBiotech Recombinant Human Proteins Product and Services
Table 22. RayBiotech Recombinant Human Proteins Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Enzyme Research Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Enzyme Research Laboratories Major Business
Table 25. Enzyme Research Laboratories Recombinant Human Proteins Product and Services
Table 26. Enzyme Research Laboratories Recombinant Human Proteins Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. HYPHEN BIOMED Basic Information, Manufacturing Base and Competitors
Table 28. HYPHEN BIOMED Major Business
Table 29. HYPHEN BIOMED Recombinant Human Proteins Product and Services
Table 30. HYPHEN BIOMED Recombinant Human Proteins Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Recombinant Human Proteins Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 32. Global Recombinant Human Proteins Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Recombinant Human Proteins, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Recombinant Human Proteins Production Capacity by Company, (K MT): 2020 VS 2021
Table 35. Head Office and Recombinant Human Proteins Production Site of Key Manufacturer
Table 36. Recombinant Human Proteins New Entrant and Capacity Expansion Plans
Table 37. Recombinant Human Proteins Mergers & Acquisitions in the Past Five Years
Table 38. Global Recombinant Human Proteins Sales by Region (2017-2022) & (K MT)
Table 39. Global Recombinant Human Proteins Sales by Region (2023-2028) & (K MT)
Table 40. Global Recombinant Human Proteins Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Recombinant Human Proteins Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Recombinant Human Proteins Sales by Type (2017-2022) & (K MT)
Table 43. Global Recombinant Human Proteins Sales by Type (2023-2028) & (K MT)
Table 44. Global Recombinant Human Proteins Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Recombinant Human Proteins Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Recombinant Human Proteins Price by Type (2017-2022) & (USD/MT)
Table 47. Global Recombinant Human Proteins Price by Type (2023-2028) & (USD/MT)
Table 48. Global Recombinant Human Proteins Sales by Application (2017-2022) & (K MT)
Table 49. Global Recombinant Human Proteins Sales by Application (2023-2028) & (K MT)
Table 50. Global Recombinant Human Proteins Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Recombinant Human Proteins Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Recombinant Human Proteins Price by Application (2017-2022) & (USD/MT)
Table 53. Global Recombinant Human Proteins Price by Application (2023-2028) & (USD/MT)
Table 54. North America Recombinant Human Proteins Sales by Country (2017-2022) & (K MT)
Table 55. North America Recombinant Human Proteins Sales by Country (2023-2028) & (K MT)
Table 56. North America Recombinant Human Proteins Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Recombinant Human Proteins Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Recombinant Human Proteins Sales by Type (2017-2022) & (K MT)
Table 59. North America Recombinant Human Proteins Sales by Type (2023-2028) & (K MT)
Table 60. North America Recombinant Human Proteins Sales by Application (2017-2022) & (K MT)
Table 61. North America Recombinant Human Proteins Sales by Application (2023-2028) & (K MT)
Table 62. Europe Recombinant Human Proteins Sales by Country (2017-2022) & (K MT)
Table 63. Europe Recombinant Human Proteins Sales by Country (2023-2028) & (K MT)
Table 64. Europe Recombinant Human Proteins Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Recombinant Human Proteins Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Recombinant Human Proteins Sales by Type (2017-2022) & (K MT)
Table 67. Europe Recombinant Human Proteins Sales by Type (2023-2028) & (K MT)
Table 68. Europe Recombinant Human Proteins Sales by Application (2017-2022) & (K MT)
Table 69. Europe Recombinant Human Proteins Sales by Application (2023-2028) & (K MT)
Table 70. Asia-Pacific Recombinant Human Proteins Sales by Region (2017-2022) & (K MT)
Table 71. Asia-Pacific Recombinant Human Proteins Sales by Region (2023-2028) & (K MT)
Table 72. Asia-Pacific Recombinant Human Proteins Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Recombinant Human Proteins Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Recombinant Human Proteins Sales by Type (2017-2022) & (K MT)
Table 75. Asia-Pacific Recombinant Human Proteins Sales by Type (2023-2028) & (K MT)
Table 76. Asia-Pacific Recombinant Human Proteins Sales by Application (2017-2022) & (K MT)
Table 77. Asia-Pacific Recombinant Human Proteins Sales by Application (2023-2028) & (K MT)
Table 78. South America Recombinant Human Proteins Sales by Country (2017-2022) & (K MT)
Table 79. South America Recombinant Human Proteins Sales by Country (2023-2028) & (K MT)
Table 80. South America Recombinant Human Proteins Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Recombinant Human Proteins Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Recombinant Human Proteins Sales by Type (2017-2022) & (K MT)
Table 83. South America Recombinant Human Proteins Sales by Type (2023-2028) & (K MT)
Table 84. South America Recombinant Human Proteins Sales by Application (2017-2022) & (K MT)
Table 85. South America Recombinant Human Proteins Sales by Application (2023-2028) & (K MT)
Table 86. Middle East & Africa Recombinant Human Proteins Sales by Region (2017-2022) & (K MT)
Table 87. Middle East & Africa Recombinant Human Proteins Sales by Region (2023-2028) & (K MT)
Table 88. Middle East & Africa Recombinant Human Proteins Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Recombinant Human Proteins Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Recombinant Human Proteins Sales by Type (2017-2022) & (K MT)
Table 91. Middle East & Africa Recombinant Human Proteins Sales by Type (2023-2028) & (K MT)
Table 92. Middle East & Africa Recombinant Human Proteins Sales by Application (2017-2022) & (K MT)
Table 93. Middle East & Africa Recombinant Human Proteins Sales by Application (2023-2028) & (K MT)
Table 94. Recombinant Human Proteins Raw Material
Table 95. Key Manufacturers of Recombinant Human Proteins Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Recombinant Human Proteins Typical Distributors
Table 99. Recombinant Human Proteins Typical Customers
List of Figures
Figure 1. Recombinant Human Proteins Picture
Figure 2. Global Recombinant Human Proteins Revenue Market Share by Type in 2021
Figure 3. Protein Production
Figure 4. Protein Purification
Figure 5. Global Recombinant Human Proteins Revenue Market Share by Application in 2021
Figure 6. Laboratories
Figure 7. Medical
Figure 8. Global Recombinant Human Proteins Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 9. Global Recombinant Human Proteins Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Recombinant Human Proteins Sales (2017-2028) & (K MT)
Figure 11. Global Recombinant Human Proteins Price (2017-2028) & (USD/MT)
Figure 12. Global Recombinant Human Proteins Production Capacity (2017-2028) & (K MT)
Figure 13. Global Recombinant Human Proteins Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Recombinant Human Proteins Market Drivers
Figure 15. Recombinant Human Proteins Market Restraints
Figure 16. Recombinant Human Proteins Market Trends
Figure 17. Global Recombinant Human Proteins Sales Market Share by Manufacturer in 2021
Figure 18. Global Recombinant Human Proteins Revenue Market Share by Manufacturer in 2021
Figure 19. Recombinant Human Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Recombinant Human Proteins Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Recombinant Human Proteins Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Recombinant Human Proteins Sales Market Share by Region (2017-2028)
Figure 23. Global Recombinant Human Proteins Revenue Market Share by Region (2017-2028)
Figure 24. North America Recombinant Human Proteins Revenue (2017-2028) & (USD Million)
Figure 25. Europe Recombinant Human Proteins Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Recombinant Human Proteins Revenue (2017-2028) & (USD Million)
Figure 27. South America Recombinant Human Proteins Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Recombinant Human Proteins Revenue (2017-2028) & (USD Million)
Figure 29. Global Recombinant Human Proteins Sales Market Share by Type (2017-2028)
Figure 30. Global Recombinant Human Proteins Revenue Market Share by Type (2017-2028)
Figure 31. Global Recombinant Human Proteins Price by Type (2017-2028) & (USD/MT)
Figure 32. Global Recombinant Human Proteins Sales Market Share by Application (2017-2028)
Figure 33. Global Recombinant Human Proteins Revenue Market Share by Application (2017-2028)
Figure 34. Global Recombinant Human Proteins Price by Application (2017-2028) & (USD/MT)
Figure 35. North America Recombinant Human Proteins Sales Market Share by Type (2017-2028)
Figure 36. North America Recombinant Human Proteins Sales Market Share by Application (2017-2028)
Figure 37. North America Recombinant Human Proteins Sales Market Share by Country (2017-2028)
Figure 38. North America Recombinant Human Proteins Revenue Market Share by Country (2017-2028)
Figure 39. United States Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Recombinant Human Proteins Sales Market Share by Type (2017-2028)
Figure 43. Europe Recombinant Human Proteins Sales Market Share by Application (2017-2028)
Figure 44. Europe Recombinant Human Proteins Sales Market Share by Country (2017-2028)
Figure 45. Europe Recombinant Human Proteins Revenue Market Share by Country (2017-2028)
Figure 46. Germany Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Recombinant Human Proteins Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Recombinant Human Proteins Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Recombinant Human Proteins Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Recombinant Human Proteins Revenue Market Share by Region (2017-2028)
Figure 55. China Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Recombinant Human Proteins Sales Market Share by Type (2017-2028)
Figure 62. South America Recombinant Human Proteins Sales Market Share by Application (2017-2028)
Figure 63. South America Recombinant Human Proteins Sales Market Share by Country (2017-2028)
Figure 64. South America Recombinant Human Proteins Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Recombinant Human Proteins Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Recombinant Human Proteins Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Recombinant Human Proteins Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Recombinant Human Proteins Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Recombinant Human Proteins Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Recombinant Human Proteins in 2021
Figure 76. Manufacturing Process Analysis of Recombinant Human Proteins
Figure 77. Recombinant Human Proteins Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の組換えヒトタンパク質市場2022年：タンパク質生産物、タンパク質精製物(Global Recombinant Human Proteins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の組換えヒトタンパク質市場2022年：タンパク質生産物、タンパク質精製物

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp